STAT6
-
出海机会来了！美国上市公司寻找STAT6 Protac或分子胶产品 | 药时代BD项目
如果贵公司对这个出海机会感兴趣，请速速联系药时代BD团队！
-
Johnson & Johnson just licensed in a STAT6 inhibitor. If you are interested in similar assets, please contact us asap 【Product for Licensing】
If you are interested in similar assets, please contact DrugTimes BD Team at BD@drugtimes.cn asap
-
Johnson & Johnson to license novel oral assets, further strengthening commitment to atopic dermatitis
Johnson & Johnson gains an exclusive license to Kaken’s STAT6 program, including lead candidate KP-723
